Subcutaneous or Transvenous Defibrillator Therapy

E. Knops, Reinoud; R.A. Olde Nordkamp, Louise; Delnoy, Peter-Paul; V.A. Boersma, Lucas; Kuschyk, Jürgen; F. El‐Chami, Mikhael; Bonnemeier, Hendrik; R. Behr, Elijah; F. Brouwer, Tom; Kääb, Stefan; Mittal, Suneet; B.E. Quast, Anne‐Floor; Smeding, Lonneke; van der Stuijt, Willeke; de Weger, Anouk; C. de Wilde, Koen; R. Bijsterveld, Nick; Richter, Sergio; A. Brouwer, Marc; R. de Groot, Joris; M. Kooiman, Kirsten; D. Lambiase, Pier; Neužil, Petr; Vernooy, Kevin; Alings, Marco; R. Betts, Timothy; Bracke, Frank; C. Burke, Martin; S.S.G. de Jong, Jonas; J. Wright, David; G.P. Tijssen, Jan; A.M. Wilde, Arthur

doi:10.1056/nejmoa1915932

Public

Subcutaneous or Transvenous Defibrillator Therapy

Published in New England Journal of Medicine • Aug 5, 2020

Authors:

Reinoud E. Knops

Louise R.A. Olde Nordkamp

Peter-Paul Delnoy

Abstract

BACKGROUND: The subcutaneous implantable cardioverter-defibrillator (ICD) was designed to avoid complications related to the transvenous ICD lead by using an entirely extrathoracic placement. Evidence comparing these systems has been based primarily on observational studies. METHODS: We conducted a ...

Subject

Medicine

Cardiology

Intensive care medicine

Research Assistant

AI chat, annotations, notes & similar papers

Finding related papers...

Discussions

(0)

No comments yet

Be the first to share your thoughts!